Upadacitinib Versus Infliximab as Second-Line Treatment for Acute Severe Ulcerative Colitis（UPRISE）
- Status
- RECRUITING
- Phase
- PHASE4
Clinical Trials Related to Infliximab
Related studies linked through entity extraction aliases.
Biologic Treatment Withdrawal in Takayasu Arteritis Patients in Sustained Remission
- Status
- RECRUITING
- Phase
- NA
Palmitoleic Acid Combined With Infliximab for Promoting Intestinal Mucosal Healing in Crohn's Disease
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Akkermansia Muciniphila Combined With Infliximab for Promoting Intestinal Mucosal Healing in Crohn's Disease
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Utilization of a Microdevice for Psoriasis and Atopic Dermatitis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Combination Therapy With Infliximab and Tofacitinib for Acute Severe Ulcerative Colitis - CINTO Trial
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study on the Relationship of Interleukin-7 Receptor Gene Polymorphisms With the Risk of Crohn's Disease Onset and the Efficacy of Infliximab
- Status
- COMPLETED
- Phase
- N/A
TNF-α Antagonists Mitigate Systemic Inflammatory Response After Cardiac Arrest.
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Efficacy and Mechanism of FMT in the Treatment of Inflammatory Bowel Disease: an Open-label Randomized Controlled Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
An Open-Label Study of Effectiveness of Immunomodulatory Medications for Patients With Relapsing Polychondritis
- Status
- RECRUITING
- Phase
- PHASE2
A Direct Head-to-head Comparison of Ustekinumab with Infliximab for the Treatment of Ulcerative Colitis
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
PROactive and Early Infliximab Monitoring and OPTimization in Inflammatory Bowel Disease
- Status
- RECRUITING
- Phase
- NA
EPIC- Extracorporeal Photopheresis (ECP) for Immune-related Colitis
- Status
- WITHDRAWN
- Phase
- PHASE2
Vedolizumab in Pediatric Ulcerative Colitis- Comparison With Infliximab
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis
- Status
- RECRUITING
- Phase
- PHASE2
Comparison Between Infliximab and Adalimumab on Patients With Ulcerative Colitis
- Status
- COMPLETED
- Phase
- N/A
Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab
- Status
- RECRUITING
- Phase
- PHASE2
Subcutaneous Infliximab After A Previous Intravenous Dose Optimization
- Status
- RECRUITING
- Phase
- PHASE4
Therapeutic Monitoring of Infliximab and Adalimumab
- Status
- UNKNOWN
- Phase
- N/A